AI Analysis AI Analysis of ALT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ALT to Watchlist?
Some Reasons Why To Add ALT:
  • Lower volatility than the market (beta 0.24)
  • Highly efficient cash conversion (100% FCF/OCF ratio)
  • RSI at 26 — potential oversold entry point
PDF

Altimmune, Inc. stock upgraded to Hold/Accumulate
(Updated on Jul 22, 2026)

Hold candidate since Jul 22, 2026

The Altimmune, Inc. stock price fell by -0.355% on the last day (Wednesday, 22nd Jul 2026) from $2.82 to $2.81. During the last trading day the stock fluctuated 3.62% from a day low at $2.77 to a day high of $2.87. The price has fallen in 6 of the last 10 days and is down by -9.65% for this period. Volume has increased on the last day by 257 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $6.29 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Altimmune, Inc. stock with a 90% probability to be traded between $2.63 and $3.33 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

ALT Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 20, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Altimmune, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.87 and $2.87. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Altimmune, Inc. stock

Altimmune, Inc. finds support from accumulated volume at $2.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.100 between high and low, or 3.62%. For the last week, the stock has had daily average volatility of 4.70%.

Our recommended stop-loss: $2.66 (-5.48%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (ALT) For The Upcoming Trading Day Of Thursday 23rd

For the upcoming trading day on Thursday, 23rd we expect Altimmune, Inc. to open at $2.81, and during the day (based on 14 day Average True Range), to move between $2.74 and $2.88, which gives a possible trading interval of +/-$0.148 (+/-5.40%) up or down from last closing price. If Altimmune, Inc. takes out the full calculated possible swing range there will be an estimated 5.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.82 (0.36%) than the support at $2.80 (0.36%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Altimmune, Inc. stock A Buy?

Altimmune, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.034 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 23, 2026 - $2.81 ( 0.119%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ALT Performance

Trading levels for ALT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.91 3.68%
R2 2.88 2.32%
R1 2.85 1.48%
Price 2.81
S1 2.78 -1.24%
S2 2.75 -2.08%
S3 2.71 -3.44%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.93 4.27%
R2 2.89 2.85%
R1 2.82 0.356%
Price 2.81
S1 2.80 -0.356%
S2 2.74 -2.49%
S3 2.70 -3.91%

ALT Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Nov 17, 2016 Feb 06, 2017 Feb 06, 2017 $873.00 0%
2 Jan 20, 2017 Jan 20, 2017 Sep 14, 2018 $873.01 16,018.53%

FAQ

What is the symbol for Altimmune, Inc. Stock and on which exchange is it traded?
The symbol for Altimmune, Inc. is ALT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Altimmune, Inc. Stock?
Altimmune, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Altimmune, Inc. Stock?
Altimmune, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Altimmune, Inc. Stock.

What's the current price of Altimmune, Inc. Stock?
As of the end of day on the Jul 22, 2026, the price of an Altimmune, Inc. (ALT) share was $2.81.

What is the 52-week high and low for Altimmune, Inc. Stock?
The 52-week high for Altimmune, Inc. Stock is $6.44 and the 52-week low is $2.56.

What is the market capitalization of Altimmune, Inc. Stock?
As of the Jul 22, 2026, the market capitalization of Altimmune, Inc. is 248.886M.

When is the next earnings date for Altimmune, Inc.?
The upcoming earnings date for Altimmune, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT ALTIMMUNE, INC.
Altimmune
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinica...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
6.70% Jul 13
JLL
$299.78
8.23% Jun 24
ROP
$331.60
5.76% Jun 24
NMRK
$15.02
4.79% Jun 24
CAG
$13.43
10.69% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE